CoChat
Cited by 165

The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.

Target 2035: probing the human proteome

Open access
Carter, Adrian J., Kraemer, Oliver, Zwick, Matthias, Mueller-Fahrnow, Anke, Arrowsmith, Cheryl H., Edwards, Aled M. · 2019 · Drug Discovery Today

Abstract

Biomedical scientists tend to focus on only a small fraction of the proteins encoded by the human genome despite overwhelming genetic evidence that many understudied proteins are important for human disease. One of the best ways to interrogate the function of a protein and to determine its relevance as a drug target is by using a pharmacological modulator, such as a chemical probe or an antibody. If these tools were available for most human proteins, it should be possible to translate the tremendous advances in genomics into a greater understanding of human health and disease, and catalyze the creation of innovative new medicines. Target 2035 is a global federation for developing and applying new technologies with the goal of creating chemogenomic libraries, chemical probes, and/or functional antibodies for the entire proteome.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.drudis.2019.06.020

Cites

19 of 19 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 27

  1. Maglott, 2007, Entrez Gene: gene-centered information at NCBI, Nucleic Acids Res., 35, D26, 10.1093/nar/gkl993 · DOI · Paper page
  2. Perc, 2014, The Matthew effect in empirical data, J. R. Soc. Interface, 11, 10.1098/rsif.2014.0378 · DOI · Paper page
  3. Barabási, 2009, Scale-free networks: a decade and beyond, Science, 325, 412, 10.1126/science.1173299 · DOI · Paper page
  4. Uhlén, 2005, A human protein atlas for normal and cancer tissues based on antibody proteomics, Mol. Cell. Proteomics, 4, 1920, 10.1074/mcp.M500279-MCP200 · DOI · Paper page
  5. HUPO, 2010, A gene-centric human proteome project, Mol. Cell. Proteomics, 9, 427, 10.1074/mcp.H900001-MCP200 · DOI
  6. Omenn, 2018, Progress on identifying and characterizing the human proteome: 2018 metrics from the HUPO Human Proteome Project, J. Proteome Res., 17, 4031, 10.1021/acs.jproteome.8b00441 · DOI
  7. Paik, 2012, The Chromosome-Centric Human Proteome Project for cataloging proteins encoded in the genome, Nat. Biotechnol., 30, 221, 10.1038/nbt.2152 · DOI · Paper page
  8. Marko-Varga, 2013, A first step toward completion of a genome-wide characterization of the human proteome, J. Proteome Res., 12, 1, 10.1021/pr301183a · DOI
  9. Paik, 2018, Launching the C-HPP neXt-CP50 pilot project for functional characterization of identified proteins with no known function, J. Proteome Res., 17, 4042, 10.1021/acs.jproteome.8b00383 · DOI
  10. Rual, 2005, Towards a proteome-scale map of the human protein–protein interaction network, Nature, 437, 1173, 10.1038/nature04209 · DOI · Paper page
  11. Rolland, 2014, A proteome-scale map of the human interactome network, Cell, 159, 1212, 10.1016/j.cell.2014.10.050 · DOI · Paper page
  12. Cafarelli, 2017, Mapping, modeling, and characterization of protein–protein interactions on a proteomic scale, Curr. Opin. Struct. Biol., 44, 201, 10.1016/j.sbi.2017.05.003 · DOI
  13. Zhang, 2018, Structure and protein interaction-based gene ontology annotations reveal likely functions of uncharacterized proteins on human chromosome 17, J. Proteome Res., 17, 4186, 10.1021/acs.jproteome.8b00453 · DOI
  14. Bredel, 2004, Chemogenomics: an emerging strategy for rapid target and drug discovery, Nat. Rev. Genet., 5, 262, 10.1038/nrg1317 · DOI · Paper page
  15. Oprea, 2018, Far away from the lamppost, PLoS Biol., 16, 10.1371/journal.pbio.3000067 · DOI
  16. Fedorov, 2010, The (un)targeted cancer kinome, Nat. Chem. Biol., 6, 166, 10.1038/nchembio.297 · DOI · Paper page
  17. Akinjiyan, 2017, Lead discovery and chemical biology approaches targeting the ubiquitin proteasome system, Bioorg. Med. Chem. Lett., 27, 4589, 10.1016/j.bmcl.2017.08.058 · DOI
  18. Robertson, 1980, Biology in the 1980s, plus or minus a decade, Nature, 285, 358, 10.1038/285358a0 · doi:10.1038/285358a0
  19. Müller, 2018, Donated chemical probes for open science, eLife, 7, e34311, 10.7554/eLife.34311 · DOI
  20. Patel, 2014, Advantages of crystallographic fragment screening: functional and mechanistic insights from a powerful platform for efficient drug discovery, Prog. Biophys. Mol. Biol., 116, 92, 10.1016/j.pbiomolbio.2014.08.004 · DOI
  21. O’Connell, 2014, Solution-based indirect affinity selection mass spectrometry—a general tool for high-throughput screening of pharmaceutical compound libraries, Anal. Chem., 86, 7413, 10.1021/ac500938y · DOI
  22. Jensen, 2015, CETSA: a target engagement assay with potential to transform drug discovery, Future Med. Chem., 7, 975, 10.4155/fmc.15.50 · DOI
  23. Barelier, 2014, Increasing chemical space coverage by combining empirical and computational fragment screens, ACS Chem. Biol., 9, 1528, 10.1021/cb5001636 · DOI
  24. Campos, 2019, The importance of synthetic chemistry in the pharmaceutical industry, Science, 363, eaat0805, 10.1126/science.aat0805 · DOI · Paper page
  25. Sachidanandam, 2001, A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms, Nature, 409, 928, 10.1038/35057149 · DOI · Paper page
  26. Edwards, 2017, A trust approach for sharing research reagents, Sci. Transl. Med., 9, eaai9055, 10.1126/scitranslmed.aai9055 · doi:10.1126/scitranslmed.aai9055
  27. Scheer, 2019, A chemical biology toolbox to study protein methyltransferases and epigenetic signaling, Nat. Commun., 10, 10.1038/s41467-018-07905-4 · DOI

Cited by

See all 165

Metadata

Authors
Carter, A. J., Kraemer, O., Zwick, M., Mueller-Fahrnow, A., Arrowsmith, C. H., & Edwards, A. M.
Venue
Drug Discovery Today
Publisher
Elsevier BV
Published
2019-11
Volume
24
Issue
11
Pages
2111-2115
ISSN
1359-6446 (ISSN-L)
OpenAlex
W2954028792
Cited by
165
References
19
FWCI
11.79
Type
journal article
Language
en
Open access
hybrid
Licence
Funders
  • AbbVie
  • Bayer
  • Boehringer Ingelheim
  • Canada Foundation for Innovation
  • Eshelman Institute for Innovation
  • Ontario Genomics Institute (OGI-055)
  • Innovative Medicines Initiative (115766)
  • Janssen
  • Merck KGaA
  • MSD
  • Novartis Pharma AG
  • Ontario Ministry of Research, Innovation and Science
  • Pfizer
  • FAPESP
  • Takeda
  • The Wellcome Trust

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.